Study of the Utility of the BOMET-QOL Questionnaire Patients With Breast Cancer and Bone Metastasis (MAbomet)

Spanish Breast Cancer Research Group (GEICAM)

Status: Completed

Conditions: Breast Carcinoma Metastatic to the Bone

Treatments: Diagnostic Test: BOMET-QoL questionnaire

Study type: Observational

Funder types: Other; Industry

Identifiers

NCT03847220

Mabomet

Details and patient eligibility

About

Epidemiological, prospective and multicenter study to evaluate the utility of the BOMET-QoL questionnaire in patients with breast cancer (BC) and bone metastases (BM).

Full description

Population: Patients over 18 with breast cancer and bone metastasis.

Inclusion criteria:

• Patient over 18 years of age.
• Patient diagnosed with breast cancer (BC) and bone metastases (BM).
• Patient who has granted informed consent in writing to participate in the study.
• Patient capable of understanding and completing the questionnaires.

Exclusion criteria:

• Patient with another type of disease that, in the investigator's opinion, could mask the study results.
• Patients with a life expectancy of less than 8 months.
• Patient who is participating in a clinical trial with an unregistered drug at the start of the study.

Enrollment: 241 patients

Sex: Female

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patient over 18 years of age.
• Patient diagnosed with BC and BM.
• Patient who has granted informed consent in writing to participate in the study.
• Patient capable of understanding and completing the questionnaires

Exclusion criteria

• Patient with another type of disease that, in the investigator's opinion, could mask the study results.
• Patients with a life expectancy of less than 8 months.
• Patient who is participating in a clinical trial with an unregistered drug at the start of the study.